TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
ESPR

Esperion Therapeutics Inc

Healthcare · Drug Manufacturers - Specialty & Generic

3.20$ +0.0% vs. previous close Closing price · As of: Jul 15, 2026

Statements

Balance Sheet

Esperion Therapeutics Inc (ESPR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 463 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ESPR
Line item Q2 16 Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
277 264 245 215 185 313 278 244 211 174 143 236 309 255 214 180 330 251 353 279 280 225 382 343 304 313 248 252 235 221 206 373 352 314 344 324 347 364 466 463
209 213 214 188 171 207 204 201 189 168 143 235 307 253 212 173 321 243 346 273 275 171 329 291 252 262 247 251 232 218 201 366 345 308 338 319 343 360 168 459
49 47 38 20 20 21 34 31 24 27 37 175 274 212 166 149 298 216 305 218 219 104 209 150 123 159 125 145 138 115 82 227 189 145 145 115 86 92 168 156
207 210 38 182 167 203 34 197 180 159 37 229 301 244 201 157 301 216 305 218 219 104 259 219 186 189 167 162 138 115 82 227 189 145 145 115 86 92 168 156
– – – – – – – – – – – – – – – – – – 12 17 22 22 23 25 28 31 34 36 41 43 48 55 60 68 80 81 108 119 140 132
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – 1.8 8.2 9.1 16 28 24 34 34 36 29 30 35 39 46 51 66 73 84 80 94 99 114 142 105 104
0.7 0.6 0.7 0.6 0.6 0.5 0.4 0.4 0.3 0.6 0.5 0.4 0.9 1.0 1.1 1.4 1.5 1.4 1.3 1.1 5.2 4.5 0.7 0.5 0.4 0.3 0.2 0.1 0.0 3.0 – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 – – 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
9.5 9.6 17 22 31 35 33 30 35 42 64 61 179 187 194 230 245 242 449 548 585 588 579 592 596 607 572 581 607 631 661 667 697 684 733 750 781 815 768 770
7.6 8.2 16 22 31 35 33 30 35 42 64 60 54 58 66 73 84 76 94 98 83 78 73 79 82 82 92 95 107 138 156 165 175 166 246 271 299 359 301 300
1.7 1.7 1.7 1.7 1.8 1.5 1.0 0.6 0.2 – – 0.4 0.4 0.5 0.5 1.9 12 14 2.6 8.7 15 19 14 16 24 20 26 28 23 38 36 46 2.7 2.7 57 57 124 152 92 82
1.6 1.8 4.6 12 19 20 20 12 22 19 45 33 28 24 29 15 30 18 52 30 29 21 18 27 13 19 23 17 25 26 32 28 48 35 52 72 75 78 65 68
1.9 1.5 1.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 – 0.8 124 128 127 – – – 179 272 272 273 258 259 259 259 260 260 261 261 262 262 262 263 238 238 243 249 249 250
268 254 229 192 154 278 245 214 176 132 79 175 129 69 20 -50 85 9.0 -96 -269 -304 -363 -197 -249 -292 -294 -324 -330 -372 -410 -455 -294 -344 -370 -389 -426 -434 -451 -302 -308
-183 -200 -229 -270 -313 -358 -396 -442 -488 -538 -598 -511 -565 -633 -695 -774 -649 -734 -839 -928 -972 -1,041 -1,106 -1,163 -1,229 -1,285 -1,340 -1,402 -1,452 -1,493 -1,549 -1,488 -1,550 -1,580 -1,601 -1,641 -1,654 -1,686 -1,624 -1,649
23 23 23 23 23 24 26 27 27 27 27 28 27 27 27 28 29 28 27 26 26 26 37 61 63 68 73 78 109 112 112 190 189 195 196 196 197 198 285 251

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: July 15, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?